LEADERS FREE Substudy Presented for Biosensors' Biofreedom Drug-Coated Stent in ACS Patients
May 31, 2016—Results from the LEADERS FREE substudy of the polymer-free Biofreedom biolimus-A9 (BA9) drug-coated stent (Biosensors International Group, Ltd) in acute coronary syndromes (ACS) were reported for the first time at the EuroPCR 2016 conference held May 17–20 in Paris, France.